Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04864561 |
| Consolidated Lead Sponsor | Valneva Austria |
| Therapeutic Condition Cohort | Infectious Disease and Vaccines |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 4,034 participants (ACTUAL) |
| Registered Start Date | 2021-04-26 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University Hospitals Birmingham NHS Foundation Trust | Birmingham, United Kingdom | Open Hospital Dossier -> |
| Barts Health NHS Trust | London, United Kingdom | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.